科索亚治疗2型糖尿病微量蛋白尿的疗效  

Investigation of curative effect of Losartan Potassium Tablets for the therapy of microalbuminuria in patient with type 2 diabetes mellitus

作　　者：李雪平 

机构地区：[1]重庆市丰都县人民医院高镇分院,408200

出　　处：《检验医学与临床》2013年第9期1074-1075,共2页Laboratory Medicine and Clinic

摘　　要：目的探讨科索亚治疗2型糖尿病微量蛋白尿的疗效。方法随机抽取丰都县人民医院高镇分院2012年1～9月的2型糖尿病患者120例,随机分成观察组和对照组,每组各60例。对照组采取常规降糖、降脂治疗,观察组在常规治疗的基础上加用科索亚口服片,50～100mg/d。治疗2周后对比分析两组患者的尿蛋白水平。结果观察组患者显效22例,有效19例,无效19例,总有效率68.3%;对照组患者显效17例,有效19例,无效24例,总有效率60.0%。观察组治疗效果优于对照组。结论科索亚治疗2型糖尿病微量尿蛋白具有较好的临床效果,值得临床应用和推广。Objective To discuss the curative effect of Losartan Potassium Tablets for the therapy of mi- croalbuminuria in patients with type 2 diabetes mellitus （T2DM）. Methods 120 cases of patients with T2DM were randomly selected and divided into observation group and control group, 60 cases for each groups. Patients in control group were treated with conventional therapy for reducing blood levels of glucose and lipids, and patients in observa tion group were treated with oral Losartan Potassium Tablets, 50-100 mg/d, except the tilerapy in control group. After 2 weeks of treatment, urinary protein levels in the two groups were compared. Results The cases of markedly improved, effective and ineffective in observation group were 22, 19 and 19, with total effective rate of 68.3%, and those in control group were 17, 19 and 24, with total effective rate of 60： 0%. The curative effect in observation group was superior than control group. Conclusion Losartan Potassium Tablets might be with fine curative effect for the therapy of microalbuminuria in patients with T2DM.

关 键 词：科索亚 2型糖尿病 微量蛋白尿 

分 类 号：R587.1[医药卫生—内分泌]